13th ANNUAL BEER INSTITUTE BREWER'S BALL
MARCH 4, 2017
CLICK HERE TO PURCHASE TICKETS

More about D.C. Brewer's Ball and the CFF

 

Be part of the best craft beer event in DC!

WHAT: The 13th Annual Beer Institute Brewer’s Ball 
has earned its reputation as the craft beer event of the season, hosting over 40 of the best breweries and 30 popular restaurants. Guests enjoy unlimited samplings of handcrafted beers and tastes of the best local cuisine. Mix, mingle, dance the night away with live entertainment, or bid on unique silent and live auction items and experiences. Take advantage of this annual tradition by inviting your family, friends, and clients to enjoy handcrafted brews and signature samplings from the hottest eateries in DC. If there’s one thing we can guarantee – you won’t leave hungry or thirsty. Act early to sponsor or attend – this event is guaranteed to sell out!

WHEN:
  Saturday, March, 4, 2017  - 7pm to Midnight

WHERE: National Building Museum, 401 F St NW, Washington D.C., 20001

ATTEND:
https://dcbrewersball.eventscff.org/site/participate.do?siteIdCode=R4S50BAT&tab=registration

DRESS CODE: Cocktail Attire

DONATE: Unable to attend but would like to make a donation? 
Please visit: 
https://dcbrewersball.eventscff.org/site/participate.do?siteIdCode=R4S50BAT&tab=donation


WHY:    Imagine struggling for every breath you take – something most people don’t have to think twice  about. For most, breathing is a voluntary act, the simple process of inhaling and exhaling to produce  oxygen in the brain. For those with cystic fibrosis (CF), this simple act is a daily battle.

The CF Foundation is the world’s leader in the  search for a cure for cystic fibrosis. We take great  pride in being one of the most efficient and effective organizations of our kind, and are careful stewards of  every dollar raised in support of our mission. Through  our venture philanthropy model, we are able to invest in promising CF research to develop a robust pipeline of  potential therapies that target the disease from every angle.

Recently, drug discovery and development programs have yielded drugs that have changed the course of cystic fibrosis. For the first time there are two FDA-approved therapies, Kalyedco and Orkambi, which treat not just the symptoms of the disease but the underlying genetic defect for a small percentage of the population.

We are optimistic about the road ahead, but it is a long one and the lives of people with CF are still cut far too short. The public’s support makes the difference in how we fulfill our mission to help people with CF live longer, healthier lives, while we search for a cure.

CONTACT:  For more information, please contact the Cystic Fibrosis Foundation Metropolitan Washington, D.C. Chapter at (301) 657-8444.

Sponsorship, Ticket Sales and Committee Participation - Erin Leahey (eleahey@cff.org)
Marketing & Tasting Stations - Jenna Vince (jswirskysacchetti@cff.org)
Auction - Chelsea Director (cdirector@cff.org)